OS analysis confirmed that the expression of GZMB was related to a poor survival in both astrocytoma and GBM, suggesting that mechanisms of survival are activated in PBTs that protect them from the activation of immune effectors. Here, GZMB is linked to astrocytoma (excluding glioblastoma).